NPR News: FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments

FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments
Gilead Science's remdesivir, an antiviral medicine being tested for treatment of COVID-19, would get a seven-year monopoly if approved by the Food and Drug Administration.

Đọc thêm tại NPR
at March 25, 2020 at 06:26AM
Health & Science